Fluoroazomycin arabinoside F-18 is under investigation in clinical trial NCT03257150 (A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.